Secondary menu
Antimicrobial Stewardship Backgrounders
Issue 26, May 2024 – Oral is the New IV Issue 25, Jan 2023 – Short Course Antimicrobial Therapy in Adults Issue 24, Dec 2022 – Use of Daptomycin Issue 23, Nov 2022 – Bacitracin & Risks Associated With Use in Surgery Issue 22, Apr 2022 – Avoid Fluoroquinolones as First-line Therapy Issue 21, Jan 2022 – Enterococcal Bloodstream Infections Issue 20, Apr 2021 – Candidemia in Non-neutropenic Adults Issue 19, Feb 2021 – Amoxicillin-clavulanate IV Issue 18, Oct 2020 – Update on Vancomycin Dosing Issue 17, May 2019 – Ceftriaxone Dosing Issue 16, November 2018 – Fluoroquinolones Issue 15, June 2018 – Antibiotics for Gram positive Infections Issue 14, July 2017 – β-lactam Allergy Issue 13, April 2017 – Aspiration: Pneumonitis vs. Pneumonia Issue 12, January 2017 – Staphylococcus aureus Bacteremia in Adults Issue 11, April 2016 – Cefazolin + Probenecid for Outpatient Treatment of Uncomplicated SSTIs Issue 10, February 2016 – Use of Oseltamivir for the Treatment of Influenza Issue 9, January 2016 – Clindamycin in Dental Infections Issue 8, Oct 2015 – Optimizing Vancomycin Dosing & Monitoring Issue 7, May 2015 - C. difficile Infection
Issue 6, March 2015 – The Day 3 Bundle: Tailoring Empiric Antimicrobial Therapy on Day 3 Issue 5, October 2014 – Short Course Therapy for Community-acquired Pneumonia (CAP) Issue 4, August 2014 – Understanding Asymptomatic Bacteriuria Issue 3, June 2014 – IV to PO Antimicrobial Therapy Conversion Issue 2, April 2014 – revised Feb 2019 - Carbapenem Conundrum Issue 1, January 2014 – revised Feb 2019 - Meropenem Therapeutic Interchange
